Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Benign thyroid nodules with RAS mutation grow faster.

Clinical endocrinology - 1 May 2016

Puzziello Alessandro, Guerra Anna, Murino Alessia, Izzo Giulia, Carrano Mario, Angrisani Elisabetta, Zeppa Pio, Marotta Vincenzo, Faggiano Antongiulio, Vitale Mario

Abstract excerpt

CONTEXT: The management of a benign thyroid nodule includes follow-up until its size requires a surgical or alternative treatment. To date, it is difficult or impossible to predict the size changes of a benign nodule in a given patient because no specific growth parameters exist. RAS mutations have been described in thyroid adenomas and hyperplastic benign nodules. OBJECTIVE: The aim of this study was to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy, Fine-Needle
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to GTP Phosphohydrolases

Share to Linear Models

Share to Membrane Proteins

Share to Proto-Oncogene Proteins p21(ras)

Share to Thyroid Gland

Share to Thyroid Nodule

Source

Identifiers

PMID: 26260959
DOI: 10.1111/cen.12875

Genes

KRAS
NRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Benign thyroid nodules with RAS mutation grow faster.PMID 26260959Read ↗

RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.Semantic proximity Read ↗

Detection of RAS mutation by pyrosequencing in thyroid cytology samples.Semantic proximity Read ↗

Utilities of RAS Mutations in Preoperative Fine Needle Biopsies for Decision Making for Thyroid Nodule Management: Results from a Single-Center Prospective Cohort.Semantic proximity Read ↗

RAS mutation and associated risk of malignancy in the thyroid gland: An FNA study with cytology-histology correlation.Semantic proximity Read ↗

The variable phenotype and low-risk nature of RAS-positive thyroid nodules.Semantic proximity Read ↗

Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid CancerSemantic proximity Read ↗

Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearerSemantic proximity Read ↗

The histologic outcomes of indeterminate thyroid nodules with rat sarcoma mutations: A case series.Semantic proximity Read ↗

Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer.Semantic proximity Read ↗

RAS Mutations in AUS/FLUS Cytology: Does it Have an Additional Role in BRAFV600E Mutation-Negative Nodules?Semantic proximity Read ↗

RAS-positive thyroid nodules.Semantic proximity Read ↗

Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.